These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38966903)

  • 1. A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12.
    Sun Q; Karafin MS; Garrett ME; Li Y; Ashley-Koch A; Telen MJ
    Transfusion; 2024 Jul; ():. PubMed ID: 38966903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A locus on chromosome 5 shows African ancestry-limited association with alloimmunization in sickle cell disease.
    Williams LM; Qi Z; Batai K; Hooker S; Hall NJ; Machado RF; Chen A; Campbell-Lee S; Guan Y; Kittles R; Hanchard NA
    Blood Adv; 2018 Dec; 2(24):3637-3647. PubMed ID: 30578281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.
    Hanchard NA; Moulds JM; Belmont JW; Chen A
    Transfus Med Hemother; 2014 Nov; 41(6):453-61. PubMed ID: 25670933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Dinardo CL; Oliveira TGM; Kelly S; Ashley-Koch A; Telen M; Schmidt LC; Castilho S; Melo K; Dezan MR; Wheeler MM; Johnsen JM; Nickerson DA; Jain D; Custer B; Pereira AC; Sabino EC;
    Transfusion; 2021 Feb; 61(2):603-616. PubMed ID: 33231305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis).
    Wong K; Lai WK; Jackson DE
    Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
    Telen MJ; Afenyi-Annan A; Garrett ME; Combs MR; Orringer EP; Ashley-Koch AE
    Transfusion; 2015 Jun; 55(6 Pt 2):1378-87. PubMed ID: 25444611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red Blood Cell Alloimmunization in Sickle Cell Disease Patients in Tanzania.
    Meda E; Magesa PM; Marlow T; Reid C; Roberts DJ; Makani J
    East Afr J Public Health; 2014; 11(2):775-780. PubMed ID: 28979065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients.
    Costa Neto A; Santos F; Ribeiro I; Oliveira V; Dezan M; Kashima S; Covas D; Pereira A; Fonseca G; Moreira F; Krieger J; Gualandro S; Rocha V; Mendrone A; Dinardo CL
    Transfusion; 2020 Jul; 60(7):1573-1578. PubMed ID: 32681817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory networks in sickle cell alloimmunization.
    Yazdanbakhsh K
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):457-461. PubMed ID: 27913516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genetic biomarkers for alloimmunization in sickle cell disease.
    Meinderts SM; Gerritsma JJ; Sins JWR; de Boer M; van Leeuwen K; Biemond BJ; Rijneveld AW; Kerkhoffs JH; Habibi A; van Bruggen R; Kuijpers TW; van der Schoot E; Pirenne F; Fijnvandraat K; Tanck MW; van den Berg TK
    Br J Haematol; 2019 Sep; 186(6):887-899. PubMed ID: 31168801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.
    Tatari-Calderone Z; Gordish-Dressman H; Fasano R; Riggs M; Fortier C; Campbell AD; Charron D; Gordeuk VR; Luban NLC; Vukmanovic S; Tamouza R
    Hum Immunol; 2016 Jan; 77(1):35-40. PubMed ID: 26476208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease.
    Chang DY; Wankier Z; Arthur CM; Stowell SR
    Presse Med; 2023 Dec; 52(4):104211. PubMed ID: 37981194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa.
    Seck M; Senghor AB; Loum M; Touré SA; Faye BF; Diallo AB; Keita M; Bousso SE; Guèye SM; Gadji M; Sall A; Touré AO; Diop S
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022004. PubMed ID: 35070211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.